Ignite Creation Date:
2024-05-06 @ 7:31 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06038474
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2023-09-08
Brief Title:
Descartes-08 for Patients With Systemic Lupus Erythematosus
Sponsor:
Cartesian Therapeutics
Organization:
Cartesian Therapeutics
Study Overview
Official Title:
Descartes-08 for Patients With Systemic Lupus Erythematosus
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SLE-001
Brief Summary:
This is a Phase II study to evaluate the safety tolerability and manufacturing feasibility of Descartes-08 CAR T-cells in patients with Systematic Lupus erythematosus SLE
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None